Assembly Biosciences (ASMB) Shares Outstanding (Diluted Average) (2021 - 2026)

Assembly Biosciences' Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $16.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 125.15% year-over-year to $16.9 million; the TTM figure through Mar 2026 stood at $16.9 million (up 125.15% YoY), while the FY2025 annual figure was $11.2 million, up 86.71% from the prior year.
• Shares Outstanding (Diluted Average) was $16.9 million for Q1 2026 at Assembly Biosciences, up from $11.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $48.3 million in Q2 2022 to a low of $4.0 million in Q4 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $14.2 million across 5 years, with a median of $6.4 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Diluted Average) plunged 91.17% in 2023, then soared 125.15% in 2026.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $4.0 million in 2022, then climbed by 13.47% to $4.6 million in 2023, then soared by 31.18% to $6.0 million in 2024, then soared by 86.71% to $11.2 million in 2025, then jumped by 50.75% to $16.9 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $16.9 million (Q1 2026), $11.2 million (Q4 2025), and $9.3 million (Q3 2025), per Business Quant data.